Clinical Trials · NCT05700877
Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Per Løgstrup Poulsen
- Enrollment
- 7,300
- Start date
- Jan 2023
- Locations
- 1 site, Denmark
- Primary endpoint
- Rates of a composite cardiovascular endpoint